3 Recruiting Indolent Systemic Mastocytosis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Recruiting Indolent Systemic Mastocytosis Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
📍 Institute for Allergy and Asthma — Wheaton, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔